Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Characteristics of Long-Term Survivors With EGFR-Mutant Metastatic NSCLC.
Journal: JTO clinical and research reports
Published: December 10, 2023
The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance.
Journal: Nature genetics
Published: June 25, 2023
Osimertinib in NSCLC With Atypical EGFR-Activating Mutations: A Retrospective Multicenter Study.
Journal: JTO clinical and research reports
Published: October 27, 2022
Small-molecule targeted therapies induce dependence on DNA double-strand break repair in residual tumor cells.
Journal: Science translational medicine
Published: March 30, 2022
Focal adhesion kinase-YAP signaling axis drives drug-tolerant persister cells and residual disease in lung cancer.
Journal: Nature communications
Published: January 04, 2022
In Response to: "Comparing Addition of Radiotherapy in EGFR- and ALK-Positive NSCLC With Brain Metastases: Are We Evaluating the Optimal Endpoint?"
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: November 19, 2021
Patient-Reported Outcomes with Selpercatinib Among Patients with RET Fusion-Positive Non-Small Cell Lung Cancer in the Phase I/II LIBRETTO-001 Trial.
Journal: The oncologist
Published: September 15, 2021
Hypersensitivity Reactions to Selpercatinib Treatment With or Without Prior Immune Checkpoint Inhibitor Therapy in Patients With NSCLC in LIBRETTO-001.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: August 20, 2021
Patient-Reported Outcomes with Selpercatinib Treatment Among Patients with RET-Mutant Medullary Thyroid Cancer in the Phase I/II LIBRETTO-001 Trial.
Journal: The oncologist
Published: June 10, 2021
Brain Metastases in EGFR- and ALK-Positive NSCLC: Outcomes of Central Nervous System-Penetrant Tyrosine Kinase Inhibitors Alone Versus in Combination With Radiation.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: June 01, 2021
Therapeutic Advances in the Management of Patients with Advanced RET Fusion-Positive Non-Small Cell Lung Cancer.
Journal: Current treatment options in oncology
Published: April 30, 2021
NTRK1 Fusions identified by non-invasive plasma next-generation sequencing (NGS) across 9 cancer types.
Journal: British journal of cancer
Published: April 25, 2021
Last Updated: 09/26/2026